Skip to content
OpenCapital
Get started

NuSkin Enterprises NUS Free cash flow margin

Free cash flow margin at other companies

Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
4.7%+0.9pp
Lifevantage Corporation logo
Lifevantage CorporationLFVN
3.8%+1.1pp
USANA Health Sciences logo
USANA Health SciencesUSNA
5.7%-1.1pp
Estee Lauder Companies Inc. logo
Estee Lauder Companies Inc.EL
8.7%+2.3pp
Herbalife logo
HerbalifeHLF
7.3%+4.0pp
Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN
-20.1%—

Other financials

Income statement

See full
Revenue$320.6M-12.0%
Gross profit$214.5M-13.2%
Operating income$4.0M+141%
Net income$1.8M-98.3%
EPS (diluted)$0.04-98.1%

Balance sheet

See full
Cash & equivalents$198.7M-2.5%
Total debt$303.6M-8.2%
Total equity$794.1M+5.3%
Total assets$1.4B-1.1%

Cash flow

See full
Operating cash flow-$3.9M-1,107%
CapEx$13.7M+1.0%
Free cash flow-$17.6M-33.6%

Valuation

See full
Market cap$256.35M-34.9%

Where this comes from

Calculated from NuSkin Enterprises’s reported figures.

free cash flow/total revenue=2.9%

Based on trailing twelve months.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NuSkin Enterprises's free cash flow margin?
NuSkin Enterprises (NUS) reported free cash flow margin of 2.9% in Q1 2026.
How has NuSkin Enterprises's free cash flow margin changed year-over-year?
NuSkin Enterprises's free cash flow margin decreased by 26.5% year-over-year, from 3.9% to 2.9%.
What is the long-term trend for NuSkin Enterprises's free cash flow margin?
Over 4 years (2020 to 2025), NuSkin Enterprises's free cash flow margin has grown at a -29.0% compound annual growth rate (CAGR), from 12.2% to 3.1%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.